

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.49677407 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.49677407 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.15102641 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.15102641 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.79065174 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.22981573 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.15021917 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.15021917 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.15021917 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.00479816 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.93254940 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.79204755 |
| 13 | urea cycle (GO:0000050) | 5.76032851 |
| 14 | urea metabolic process (GO:0019627) | 5.76032851 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.68288580 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.59556011 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.55199469 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.40680582 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.40323936 |
| 20 | cysteine metabolic process (GO:0006534) | 5.38834251 |
| 21 | complement activation, alternative pathway (GO:0006957) | 5.33878946 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 5.32665813 |
| 23 | nitrogen cycle metabolic process (GO:0071941) | 5.29286898 |
| 24 | regulation of protein activation cascade (GO:2000257) | 5.27154905 |
| 25 | protein carboxylation (GO:0018214) | 5.22370383 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.22370383 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.21263786 |
| 28 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.13046942 |
| 29 | negative regulation of cell killing (GO:0031342) | 5.13046942 |
| 30 | bile acid metabolic process (GO:0008206) | 5.08790685 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 5.06521261 |
| 32 | homocysteine metabolic process (GO:0050667) | 5.01912621 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.96167618 |
| 34 | regulation of complement activation (GO:0030449) | 4.93633644 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.93149929 |
| 36 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.90856230 |
| 37 | detection of molecule of bacterial origin (GO:0032490) | 4.89112477 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.85140563 |
| 39 | regulation of cholesterol esterification (GO:0010872) | 4.79265758 |
| 40 | tyrosine metabolic process (GO:0006570) | 4.77208154 |
| 41 | neutrophil activation involved in immune response (GO:0002283) | 4.73670538 |
| 42 | reverse cholesterol transport (GO:0043691) | 4.73147794 |
| 43 | lysine metabolic process (GO:0006553) | 4.72393353 |
| 44 | lysine catabolic process (GO:0006554) | 4.72393353 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.68010717 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.68010717 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.68010717 |
| 48 | amino-acid betaine metabolic process (GO:0006577) | 4.66496321 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 4.63521611 |
| 50 | positive regulation by symbiont of host defense response (GO:0052509) | 4.62157094 |
| 51 | modulation by symbiont of host defense response (GO:0052031) | 4.62157094 |
| 52 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.62157094 |
| 53 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.62157094 |
| 54 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.62157094 |
| 55 | modulation by symbiont of host immune response (GO:0052553) | 4.62157094 |
| 56 | acylglycerol homeostasis (GO:0055090) | 4.55973629 |
| 57 | triglyceride homeostasis (GO:0070328) | 4.55973629 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.51492547 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.51492547 |
| 60 | phospholipid efflux (GO:0033700) | 4.49852216 |
| 61 | bile acid and bile salt transport (GO:0015721) | 4.47993422 |
| 62 | detection of other organism (GO:0098543) | 4.41476315 |
| 63 | cellular extravasation (GO:0045123) | 4.41463878 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 4.36820865 |
| 65 | indolalkylamine metabolic process (GO:0006586) | 4.36319383 |
| 66 | cellular glucuronidation (GO:0052695) | 4.34841516 |
| 67 | coenzyme catabolic process (GO:0009109) | 4.34488790 |
| 68 | glycine metabolic process (GO:0006544) | 4.31174258 |
| 69 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.28837367 |
| 70 | cellular amino acid catabolic process (GO:0009063) | 4.27670604 |
| 71 | macrophage activation involved in immune response (GO:0002281) | 4.27405780 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 4.27008268 |
| 73 | imidazole-containing compound metabolic process (GO:0052803) | 4.25404014 |
| 74 | amine catabolic process (GO:0009310) | 4.25306069 |
| 75 | cellular biogenic amine catabolic process (GO:0042402) | 4.25306069 |
| 76 | glutamate metabolic process (GO:0006536) | 4.23332891 |
| 77 | detection of external biotic stimulus (GO:0098581) | 4.23107354 |
| 78 | cholesterol efflux (GO:0033344) | 4.19283081 |
| 79 | response to peptidoglycan (GO:0032494) | 4.15769212 |
| 80 | negative regulation of interleukin-12 production (GO:0032695) | 4.15333128 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 4.14596523 |
| 82 | regulation of gamma-delta T cell activation (GO:0046643) | 4.13586439 |
| 83 | benzene-containing compound metabolic process (GO:0042537) | 4.11676649 |
| 84 | drug catabolic process (GO:0042737) | 4.10535372 |
| 85 | ethanol oxidation (GO:0006069) | 4.10259530 |
| 86 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.09977118 |
| 87 | microglial cell activation (GO:0001774) | 4.09937238 |
| 88 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.06403017 |
| 89 | cellular modified amino acid catabolic process (GO:0042219) | 4.06252611 |
| 90 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.01562799 |
| 91 | arginine metabolic process (GO:0006525) | 3.99986440 |
| 92 | plasma lipoprotein particle assembly (GO:0034377) | 3.98518584 |
| 93 | low-density lipoprotein particle remodeling (GO:0034374) | 3.95944537 |
| 94 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.95569875 |
| 95 | serine family amino acid biosynthetic process (GO:0009070) | 3.95564563 |
| 96 | regulation of bile acid biosynthetic process (GO:0070857) | 3.93492912 |
| 97 | detection of bacterium (GO:0016045) | 3.89991856 |
| 98 | fibrinolysis (GO:0042730) | 3.88584094 |
| 99 | aldehyde catabolic process (GO:0046185) | 3.88209010 |
| 100 | glucuronate metabolic process (GO:0019585) | 3.87115731 |
| 101 | uronic acid metabolic process (GO:0006063) | 3.87115731 |
| 102 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.81467221 |
| 103 | positive regulation of lipid catabolic process (GO:0050996) | 3.78579634 |
| 104 | ketone body metabolic process (GO:1902224) | 3.78067178 |
| 105 | cholesterol homeostasis (GO:0042632) | 3.77139977 |
| 106 | phospholipid homeostasis (GO:0055091) | 3.76981140 |
| 107 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.76226757 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 3.76008215 |
| 109 | organic acid catabolic process (GO:0016054) | 3.76008215 |
| 110 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.75413449 |
| 111 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.75413449 |
| 112 | acetyl-CoA metabolic process (GO:0006084) | 3.75217898 |
| 113 | short-chain fatty acid metabolic process (GO:0046459) | 3.73242712 |
| 114 | detection of biotic stimulus (GO:0009595) | 3.73019970 |
| 115 | sterol homeostasis (GO:0055092) | 3.71187560 |
| 116 | cofactor catabolic process (GO:0051187) | 3.70950735 |
| 117 | blood coagulation, intrinsic pathway (GO:0007597) | 3.70214465 |
| 118 | complement activation, classical pathway (GO:0006958) | 3.70024649 |
| 119 | regulation of cholesterol homeostasis (GO:2000188) | 3.69426072 |
| 120 | complement activation (GO:0006956) | 3.68061174 |
| 121 | negative regulation of lipase activity (GO:0060192) | 3.66781052 |
| 122 | cytolysis (GO:0019835) | 3.65316079 |
| 123 | protein activation cascade (GO:0072376) | 3.63886393 |
| 124 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.62669398 |
| 125 | flavonoid metabolic process (GO:0009812) | 3.62583409 |
| 126 | macrophage activation (GO:0042116) | 3.58804589 |
| 127 | protein-lipid complex assembly (GO:0065005) | 3.58196056 |
| 128 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.58170577 |
| 129 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.57958420 |
| 130 | plasma lipoprotein particle organization (GO:0071827) | 3.57479478 |
| 131 | exogenous drug catabolic process (GO:0042738) | 3.57376148 |
| 132 | positive regulation of mast cell activation (GO:0033005) | 3.47236236 |
| 133 | immunoglobulin mediated immune response (GO:0016064) | 3.45940140 |
| 134 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.38551024 |
| 135 | neutrophil activation (GO:0042119) | 3.37218829 |
| 136 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.32905666 |
| 137 | response to host immune response (GO:0052572) | 3.31873756 |
| 138 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.31873756 |
| 139 | myeloid cell activation involved in immune response (GO:0002275) | 3.30118412 |
| 140 | negative regulation of T cell mediated immunity (GO:0002710) | 3.18877509 |
| 141 | regulation of mast cell degranulation (GO:0043304) | 3.14975887 |
| 142 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.14298354 |
| 143 | neutrophil mediated immunity (GO:0002446) | 3.13852689 |
| 144 | granulocyte activation (GO:0036230) | 3.12961076 |
| 145 | response to host (GO:0075136) | 3.11899270 |
| 146 | response to host defenses (GO:0052200) | 3.11899270 |
| 147 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.11899270 |
| 148 | regulation of mast cell activation (GO:0033003) | 3.11345862 |
| 149 | negative thymic T cell selection (GO:0045060) | 3.10483465 |
| 150 | leukocyte aggregation (GO:0070486) | 3.10154123 |
| 151 | negative T cell selection (GO:0043383) | 3.08922124 |
| 152 | B cell receptor signaling pathway (GO:0050853) | 3.03726340 |
| 153 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.01536280 |
| 154 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.00256015 |
| 155 | positive regulation of mast cell degranulation (GO:0043306) | 2.99209042 |
| 156 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.99209042 |
| 157 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.98393584 |
| 158 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.98250352 |
| 159 | positive regulation of B cell differentiation (GO:0045579) | 2.96929575 |
| 160 | response to interleukin-15 (GO:0070672) | 2.96729628 |
| 161 | cellular response to ethanol (GO:0071361) | 2.96017045 |
| 162 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.95739825 |
| 163 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.95239130 |
| 164 | regulation of tolerance induction (GO:0002643) | 2.94972548 |
| 165 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93570364 |
| 166 | myeloid leukocyte mediated immunity (GO:0002444) | 2.90653137 |
| 167 | regulation of macrophage cytokine production (GO:0010935) | 2.90604652 |
| 168 | negative regulation of interleukin-17 production (GO:0032700) | 2.89560071 |
| 169 | positive thymic T cell selection (GO:0045059) | 2.88720198 |
| 170 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.87335618 |
| 171 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.85764361 |
| 172 | respiratory burst (GO:0045730) | 2.84631870 |
| 173 | T cell migration (GO:0072678) | 2.84431103 |
| 174 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.81531275 |
| 175 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.81160368 |
| 176 | regulation of leukocyte degranulation (GO:0043300) | 2.79409937 |
| 177 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.77898877 |
| 178 | positive regulation of macrophage cytokine production (GO:0060907) | 2.76968154 |
| 179 | T-helper 1 type immune response (GO:0042088) | 2.75590751 |
| 180 | regulation of B cell differentiation (GO:0045577) | 2.73823418 |
| 181 | response to muramyl dipeptide (GO:0032495) | 2.73780932 |
| 182 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.73043323 |
| 183 | germinal center formation (GO:0002467) | 2.72134417 |
| 184 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.71879203 |
| 185 | positive T cell selection (GO:0043368) | 2.71159584 |
| 186 | cellular response to interleukin-15 (GO:0071350) | 2.71064293 |
| 187 | regulation of T cell tolerance induction (GO:0002664) | 2.66611322 |
| 188 | B cell mediated immunity (GO:0019724) | 2.66550585 |
| 189 | defense response to protozoan (GO:0042832) | 2.63476561 |
| 190 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.62594031 |
| 191 | cellular response to type I interferon (GO:0071357) | 2.62437007 |
| 192 | type I interferon signaling pathway (GO:0060337) | 2.62437007 |
| 193 | myeloid leukocyte activation (GO:0002274) | 2.62413039 |
| 194 | positive regulation of tolerance induction (GO:0002645) | 2.62206482 |
| 195 | response to type I interferon (GO:0034340) | 2.61259299 |
| 196 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.60968645 |
| 197 | dendritic cell migration (GO:0036336) | 2.60571805 |
| 198 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.58512705 |
| 199 | phagocytosis, engulfment (GO:0006911) | 2.55236172 |
| 200 | activated T cell proliferation (GO:0050798) | 2.53974950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.26765237 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.08714772 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.92169457 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.45944630 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.23831005 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.02523640 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.93955413 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.83417337 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.06095058 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.94874410 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.92100422 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.85481288 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.46479810 |
| 14 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.32819179 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.23317335 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.22824974 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.16026038 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.98663359 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.92903033 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.75800470 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.74946241 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.55356556 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.40285071 |
| 24 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.27830977 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.15322139 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 2.13197011 |
| 27 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03536221 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 2.03083924 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.02330290 |
| 30 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.00148507 |
| 31 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7572395 |
| 32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97708456 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.79197762 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77003775 |
| 35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.76924135 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.74139031 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.73884192 |
| 38 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.73006058 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.72729123 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68126360 |
| 41 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.65418459 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.64565631 |
| 43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.63934832 |
| 44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.61890125 |
| 45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60759896 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.57161049 |
| 47 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.55766432 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54940719 |
| 49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.53116810 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52525000 |
| 51 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.46759151 |
| 52 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.46186789 |
| 53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44431486 |
| 54 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.43141354 |
| 55 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.41381797 |
| 56 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37495400 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.34447062 |
| 58 | MAF_26560356_Chip-Seq_TH1_Human | 1.31997889 |
| 59 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31826666 |
| 60 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31285290 |
| 61 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28880675 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25091932 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22282061 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20815704 |
| 65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19949401 |
| 66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19671684 |
| 67 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17145080 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15042870 |
| 69 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14866876 |
| 70 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14494433 |
| 71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12990425 |
| 72 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10370370 |
| 73 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.05610352 |
| 74 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05249539 |
| 75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04042457 |
| 76 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03431136 |
| 77 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02797951 |
| 78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01856985 |
| 79 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01318682 |
| 80 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00730622 |
| 81 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00621902 |
| 82 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.00238609 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92154621 |
| 84 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91589317 |
| 85 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90451452 |
| 86 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90390281 |
| 87 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89957467 |
| 88 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.89296535 |
| 89 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89088516 |
| 90 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88251567 |
| 91 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.87692002 |
| 92 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86461025 |
| 93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85498319 |
| 94 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.83405969 |
| 95 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.83250331 |
| 96 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.82957428 |
| 97 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82188992 |
| 98 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82091183 |
| 99 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80891462 |
| 100 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80667520 |
| 101 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.80501575 |
| 102 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78745353 |
| 103 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78512153 |
| 104 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.78383863 |
| 105 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.77491993 |
| 106 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77474877 |
| 107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76044917 |
| 108 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75957623 |
| 109 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.75671276 |
| 110 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.75497846 |
| 111 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74560318 |
| 112 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73564646 |
| 113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73167948 |
| 114 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.73123757 |
| 115 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.73123757 |
| 116 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72703854 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71820670 |
| 118 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71274054 |
| 119 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.70931142 |
| 120 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70865946 |
| 121 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.70026081 |
| 122 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69638523 |
| 123 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.68690064 |
| 124 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67208009 |
| 125 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67208009 |
| 126 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.65954378 |
| 127 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.61358051 |
| 128 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.60919939 |
| 129 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60887434 |
| 130 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59954595 |
| 131 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58534715 |
| 132 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57834861 |
| 133 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.56510301 |
| 134 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.56243925 |
| 135 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.56055739 |
| 136 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55307595 |
| 137 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.55013825 |
| 138 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.54844916 |
| 139 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53838576 |
| 140 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52943192 |
| 141 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.51537567 |
| 142 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51000860 |
| 143 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50916881 |
| 144 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.50798926 |
| 145 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50619863 |
| 146 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.50447301 |
| 147 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.50245426 |
| 148 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.48987462 |
| 149 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.48117262 |
| 150 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.48008365 |
| 151 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.47245826 |
| 152 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.47211689 |
| 153 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.46990100 |
| 154 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46627518 |
| 155 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.45933418 |
| 156 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45506545 |
| 157 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.45327733 |
| 158 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.45041561 |
| 159 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44282547 |
| 160 | GATA2_19941826_ChIP-Seq_K562_Human | 0.43339211 |
| 161 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42835465 |
| 162 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41882044 |
| 163 | GATA1_19941826_ChIP-Seq_K562_Human | 0.41641496 |
| 164 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.40691838 |
| 165 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.40417534 |
| 166 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.40299919 |
| 167 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39925747 |
| 168 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.39721467 |
| 169 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.39654999 |
| 170 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.39189164 |
| 171 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.38572828 |
| 172 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.38164071 |
| 173 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.37831985 |
| 174 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37343929 |
| 175 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36111881 |
| 176 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.36040819 |
| 177 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35901605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.22750367 |
| 2 | MP0005360_urolithiasis | 7.77724644 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.48167776 |
| 4 | MP0005365_abnormal_bile_salt | 6.15905618 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.17140499 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.14040233 |
| 7 | MP0003252_abnormal_bile_duct | 4.00648632 |
| 8 | MP0001835_abnormal_antigen_presentation | 3.62596397 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.57778375 |
| 10 | MP0003303_peritoneal_inflammation | 3.20444744 |
| 11 | MP0009840_abnormal_foam_cell | 3.17131931 |
| 12 | MP0005083_abnormal_biliary_tract | 2.97766587 |
| 13 | MP0005332_abnormal_amino_acid | 2.80872953 |
| 14 | MP0003195_calcinosis | 2.77308947 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.75788009 |
| 16 | MP0002419_abnormal_innate_immunity | 2.74169430 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.55525543 |
| 18 | MP0009785_altered_susceptibility_to | 2.49541869 |
| 19 | MP0000685_abnormal_immune_system | 2.47550364 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.46366009 |
| 21 | MP0001800_abnormal_humoral_immune | 2.41369223 |
| 22 | MP0005671_abnormal_response_to | 2.41202323 |
| 23 | MP0005025_abnormal_response_to | 2.33807095 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.32860961 |
| 25 | MP0001790_abnormal_immune_system | 2.30544295 |
| 26 | MP0005387_immune_system_phenotype | 2.30544295 |
| 27 | MP0000569_abnormal_digit_pigmentation | 2.30042901 |
| 28 | MP0003828_pulmonary_edema | 2.26573261 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 2.20488745 |
| 30 | MP0002452_abnormal_antigen_presenting | 2.19064435 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 2.18163726 |
| 32 | MP0002723_abnormal_immune_serum | 2.17853121 |
| 33 | MP0000609_abnormal_liver_physiology | 2.14048356 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 2.10162851 |
| 35 | MP0003763_abnormal_thymus_physiology | 2.07103927 |
| 36 | MP0002420_abnormal_adaptive_immunity | 2.01446811 |
| 37 | MP0001819_abnormal_immune_cell | 1.99230661 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.98665278 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.98189623 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.93841781 |
| 41 | MP0003868_abnormal_feces_composition | 1.92294160 |
| 42 | MP0002405_respiratory_system_inflammati | 1.82221549 |
| 43 | MP0008260_abnormal_autophagy | 1.81998950 |
| 44 | MP0005319_abnormal_enzyme/_coenzyme | 1.81697759 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.74421969 |
| 46 | MP0006054_spinal_hemorrhage | 1.74059304 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.70977922 |
| 48 | MP0001764_abnormal_homeostasis | 1.66043963 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.63448609 |
| 50 | MP0009697_abnormal_copulation | 1.61273489 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.58383586 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56156578 |
| 53 | MP0005164_abnormal_response_to | 1.54346728 |
| 54 | MP0004947_skin_inflammation | 1.53940527 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.51527043 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.51461876 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.51461876 |
| 58 | MP0000716_abnormal_immune_system | 1.49903207 |
| 59 | MP0002398_abnormal_bone_marrow | 1.48457582 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.46014123 |
| 61 | MP0008004_abnormal_stomach_pH | 1.44704926 |
| 62 | MP0005451_abnormal_body_composition | 1.41459162 |
| 63 | MP0001851_eye_inflammation | 1.39250302 |
| 64 | MP0000343_altered_response_to | 1.36506191 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.30792325 |
| 66 | MP0000858_altered_metastatic_potential | 1.29187830 |
| 67 | MP0009643_abnormal_urine_homeostasis | 1.28115333 |
| 68 | MP0003011_delayed_dark_adaptation | 1.26884242 |
| 69 | MP0001958_emphysema | 1.25467506 |
| 70 | MP0003186_abnormal_redox_activity | 1.21651241 |
| 71 | MP0002722_abnormal_immune_system | 1.20863143 |
| 72 | MP0009278_abnormal_bone_marrow | 1.20204979 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 1.17149803 |
| 74 | MP0002132_abnormal_respiratory_system | 1.15858090 |
| 75 | MP0003183_abnormal_peptide_metabolism | 1.15645246 |
| 76 | MP0009333_abnormal_splenocyte_physiolog | 1.15386289 |
| 77 | MP0003705_abnormal_hypodermis_morpholog | 1.15104095 |
| 78 | MP0002429_abnormal_blood_cell | 1.15038906 |
| 79 | MP0000598_abnormal_liver_morphology | 1.14835791 |
| 80 | MP0003091_abnormal_cell_migration | 1.14513652 |
| 81 | MP0003866_abnormal_defecation | 1.11745771 |
| 82 | MP0005310_abnormal_salivary_gland | 1.11341786 |
| 83 | MP0003448_altered_tumor_morphology | 1.09470031 |
| 84 | MP0005647_abnormal_sex_gland | 1.08955337 |
| 85 | MP0002254_reproductive_system_inflammat | 1.05573406 |
| 86 | MP0000015_abnormal_ear_pigmentation | 1.04070123 |
| 87 | MP0009764_decreased_sensitivity_to | 1.03862247 |
| 88 | MP0000604_amyloidosis | 1.02509736 |
| 89 | MP0009763_increased_sensitivity_to | 0.98169720 |
| 90 | MP0002332_abnormal_exercise_endurance | 0.96397514 |
| 91 | MP0004510_myositis | 0.95631494 |
| 92 | MP0005636_abnormal_mineral_homeostasis | 0.93699796 |
| 93 | MP0002006_tumorigenesis | 0.93530263 |
| 94 | MP0003045_fibrosis | 0.93051603 |
| 95 | MP0000703_abnormal_thymus_morphology | 0.92297161 |
| 96 | MP0005670_abnormal_white_adipose | 0.91252830 |
| 97 | MP0002009_preneoplasia | 0.90468242 |
| 98 | MP0004808_abnormal_hematopoietic_stem | 0.88409730 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.86654842 |
| 100 | MP0010368_abnormal_lymphatic_system | 0.86366465 |
| 101 | MP0009642_abnormal_blood_homeostasis | 0.86058641 |
| 102 | MP0003279_aneurysm | 0.85459912 |
| 103 | MP0008469_abnormal_protein_level | 0.85339960 |
| 104 | MP0002396_abnormal_hematopoietic_system | 0.85312271 |
| 105 | MP0005408_hypopigmentation | 0.83191606 |
| 106 | MP0005390_skeleton_phenotype | 0.82484705 |
| 107 | MP0002876_abnormal_thyroid_physiology | 0.82052304 |
| 108 | MP0006036_abnormal_mitochondrial_physio | 0.79549257 |
| 109 | MP0005376_homeostasis/metabolism_phenot | 0.79113835 |
| 110 | MP0002078_abnormal_glucose_homeostasis | 0.78092014 |
| 111 | MP0009765_abnormal_xenobiotic_induced | 0.77949107 |
| 112 | MP0002133_abnormal_respiratory_system | 0.76620740 |
| 113 | MP0005388_respiratory_system_phenotype | 0.76620740 |
| 114 | MP0005174_abnormal_tail_pigmentation | 0.76159054 |
| 115 | MP0002971_abnormal_brown_adipose | 0.74945287 |
| 116 | MP0004130_abnormal_muscle_cell | 0.73094304 |
| 117 | MP0003795_abnormal_bone_structure | 0.73002086 |
| 118 | MP0005220_abnormal_exocrine_pancreas | 0.71563620 |
| 119 | MP0002933_joint_inflammation | 0.71234973 |
| 120 | MP0008438_abnormal_cutaneous_collagen | 0.71136187 |
| 121 | MP0005334_abnormal_fat_pad | 0.70980719 |
| 122 | MP0005535_abnormal_body_temperature | 0.69975354 |
| 123 | MP0001663_abnormal_digestive_system | 0.69248128 |
| 124 | MP0004484_altered_response_of | 0.68818887 |
| 125 | MP0001661_extended_life_span | 0.67042947 |
| 126 | MP0003690_abnormal_glial_cell | 0.65818062 |
| 127 | MP0000920_abnormal_myelination | 0.65799690 |
| 128 | MP0005266_abnormal_metabolism | 0.65564103 |
| 129 | MP0009053_abnormal_anal_canal | 0.64392183 |
| 130 | MP0005023_abnormal_wound_healing | 0.64267858 |
| 131 | MP0001756_abnormal_urination | 0.62976264 |
| 132 | MP0002822_catalepsy | 0.60789508 |
| 133 | MP0003329_amyloid_beta_deposits | 0.60749054 |
| 134 | MP0005448_abnormal_energy_balance | 0.59991328 |
| 135 | MP0000371_diluted_coat_color | 0.58982800 |
| 136 | MP0000639_abnormal_adrenal_gland | 0.56928630 |
| 137 | MP0006035_abnormal_mitochondrial_morpho | 0.56463395 |
| 138 | MP0002136_abnormal_kidney_physiology | 0.49004433 |
| 139 | MP0002928_abnormal_bile_duct | 0.46864858 |
| 140 | MP0003638_abnormal_response/metabolism_ | 0.46546092 |
| 141 | MP0005395_other_phenotype | 0.46145192 |
| 142 | MP0005464_abnormal_platelet_physiology | 0.45975938 |
| 143 | MP0005666_abnormal_adipose_tissue | 0.45869139 |
| 144 | MP0008874_decreased_physiological_sensi | 0.44361765 |
| 145 | MP0004782_abnormal_surfactant_physiolog | 0.43112119 |
| 146 | MP0008873_increased_physiological_sensi | 0.42635745 |
| 147 | MP0008872_abnormal_physiological_respon | 0.41925347 |
| 148 | MP0003718_maternal_effect | 0.41860569 |
| 149 | MP0003953_abnormal_hormone_level | 0.41545386 |
| 150 | MP0002837_dystrophic_cardiac_calcinosis | 0.41275132 |
| 151 | MP0003724_increased_susceptibility_to | 0.39822894 |
| 152 | MP0005248_abnormal_Harderian_gland | 0.39112398 |
| 153 | MP0000579_abnormal_nail_morphology | 0.37869843 |
| 154 | MP0003075_altered_response_to | 0.37591551 |
| 155 | MP0005166_decreased_susceptibility_to | 0.37493225 |
| 156 | MP0004381_abnormal_hair_follicle | 0.37429196 |
| 157 | MP0009384_cardiac_valve_regurgitation | 0.37211724 |
| 158 | MP0000230_abnormal_systemic_arterial | 0.35643247 |
| 159 | MP0009115_abnormal_fat_cell | 0.35573613 |
| 160 | MP0002796_impaired_skin_barrier | 0.35082794 |
| 161 | MP0003436_decreased_susceptibility_to | 0.34122023 |
| 162 | MP0009672_abnormal_birth_weight | 0.33217729 |
| 163 | MP0002168_other_aberrant_phenotype | 0.31501415 |
| 164 | MP0002970_abnormal_white_adipose | 0.30340579 |
| 165 | MP0000249_abnormal_blood_vessel | 0.30093906 |
| 166 | MP0004264_abnormal_extraembryonic_tissu | 0.29937043 |
| 167 | MP0001881_abnormal_mammary_gland | 0.28828967 |
| 168 | MP0004043_abnormal_pH_regulation | 0.28125419 |
| 169 | MP0004883_abnormal_blood_vessel | 0.27732519 |
| 170 | MP0005167_abnormal_blood-brain_barrier | 0.27608840 |
| 171 | MP0001853_heart_inflammation | 0.27352133 |
| 172 | MP0001243_abnormal_dermal_layer | 0.27142278 |
| 173 | MP0010234_abnormal_vibrissa_follicle | 0.26830193 |
| 174 | MP0002060_abnormal_skin_morphology | 0.25730246 |
| 175 | MP0006082_CNS_inflammation | 0.25294205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.33038659 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.28770429 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.25587963 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.71011670 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.52058484 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.41770622 |
| 7 | Xanthomatosis (HP:0000991) | 6.27573426 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 5.52362543 |
| 9 | Complement deficiency (HP:0004431) | 5.40915597 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 5.40843850 |
| 11 | Eczematoid dermatitis (HP:0000976) | 5.33038898 |
| 12 | Recurrent abscess formation (HP:0002722) | 5.26900487 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.80566045 |
| 14 | Hyperammonemia (HP:0001987) | 4.67046439 |
| 15 | Joint hemorrhage (HP:0005261) | 4.67016080 |
| 16 | Myositis (HP:0100614) | 4.65157823 |
| 17 | Epidermoid cyst (HP:0200040) | 4.63663008 |
| 18 | Orchitis (HP:0100796) | 4.52254188 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.44356249 |
| 20 | Hyperglycinemia (HP:0002154) | 4.44073356 |
| 21 | Optic neuritis (HP:0100653) | 4.42444867 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 4.42444867 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.39484116 |
| 24 | Abnormality of macrophages (HP:0004311) | 4.39464613 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 4.37845674 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.30154478 |
| 27 | Ketosis (HP:0001946) | 4.29149536 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 4.24954557 |
| 29 | Fat malabsorption (HP:0002630) | 4.24039563 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.23350170 |
| 31 | Hyperglycinuria (HP:0003108) | 4.12520330 |
| 32 | Hypoalphalipoproteinemia (HP:0003233) | 4.09257440 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.04336279 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 4.04336279 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.92659462 |
| 36 | Abnormality of complement system (HP:0005339) | 3.92210803 |
| 37 | Hypoglycemic coma (HP:0001325) | 3.87784955 |
| 38 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.85009900 |
| 39 | T lymphocytopenia (HP:0005403) | 3.80088214 |
| 40 | Recurrent skin infections (HP:0001581) | 3.75071496 |
| 41 | Stomatitis (HP:0010280) | 3.72581656 |
| 42 | Abnormality of the intrinsic pathway (HP:0010989) | 3.68653319 |
| 43 | Hypercholesterolemia (HP:0003124) | 3.67331466 |
| 44 | Abnormality of T cell number (HP:0011839) | 3.66046831 |
| 45 | Spontaneous hematomas (HP:0007420) | 3.56328523 |
| 46 | Recurrent fungal infections (HP:0002841) | 3.55360756 |
| 47 | Gastrointestinal infarctions (HP:0005244) | 3.53856373 |
| 48 | Abnormality of glycolipid metabolism (HP:0010969) | 3.42988248 |
| 49 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.42988248 |
| 50 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.42988248 |
| 51 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.39952276 |
| 52 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.38219250 |
| 53 | Gingivitis (HP:0000230) | 3.38119787 |
| 54 | Hyperbilirubinemia (HP:0002904) | 3.33116488 |
| 55 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.30671189 |
| 56 | Recurrent cutaneous fungal infections (HP:0011370) | 3.30671189 |
| 57 | Prolonged bleeding time (HP:0003010) | 3.28296391 |
| 58 | Keratoconjunctivitis sicca (HP:0001097) | 3.26446737 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 3.25984467 |
| 60 | Epistaxis (HP:0000421) | 3.19233698 |
| 61 | Delayed CNS myelination (HP:0002188) | 3.12337734 |
| 62 | Ketoacidosis (HP:0001993) | 3.11785400 |
| 63 | Keratoconjunctivitis (HP:0001096) | 3.11306274 |
| 64 | Peritonitis (HP:0002586) | 3.10999327 |
| 65 | Steatorrhea (HP:0002570) | 3.10988484 |
| 66 | Abnormality of serum amino acid levels (HP:0003112) | 3.07906216 |
| 67 | * Abnormality of pyrimidine metabolism (HP:0004353) | 3.04687381 |
| 68 | Meningitis (HP:0001287) | 2.97691368 |
| 69 | Pulmonary infiltrates (HP:0002113) | 2.97131710 |
| 70 | Hepatocellular carcinoma (HP:0001402) | 2.95982820 |
| 71 | Arterial thrombosis (HP:0004420) | 2.95331311 |
| 72 | Vasculitis (HP:0002633) | 2.94154859 |
| 73 | Spontaneous abortion (HP:0005268) | 2.93180961 |
| 74 | Hemoptysis (HP:0002105) | 2.90853710 |
| 75 | Myocardial infarction (HP:0001658) | 2.90407333 |
| 76 | Skin nodule (HP:0200036) | 2.87341699 |
| 77 | * Abnormality of nucleobase metabolism (HP:0010932) | 2.86095855 |
| 78 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.84695640 |
| 79 | Hypochromic microcytic anemia (HP:0004840) | 2.84591595 |
| 80 | Metabolic acidosis (HP:0001942) | 2.81208678 |
| 81 | Chest pain (HP:0100749) | 2.79123174 |
| 82 | Encephalitis (HP:0002383) | 2.79015877 |
| 83 | Obstructive lung disease (HP:0006536) | 2.78590451 |
| 84 | Chronic obstructive pulmonary disease (HP:0006510) | 2.78590451 |
| 85 | Acanthocytosis (HP:0001927) | 2.77652944 |
| 86 | Abnormality of purine metabolism (HP:0004352) | 2.77645162 |
| 87 | Leukocytosis (HP:0001974) | 2.75208335 |
| 88 | Systemic lupus erythematosus (HP:0002725) | 2.72416814 |
| 89 | Recurrent viral infections (HP:0004429) | 2.71355132 |
| 90 | Dysostosis multiplex (HP:0000943) | 2.64231968 |
| 91 | Urticaria (HP:0001025) | 2.61779943 |
| 92 | Dicarboxylic aciduria (HP:0003215) | 2.59662555 |
| 93 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.59662555 |
| 94 | Vascular calcification (HP:0004934) | 2.59008548 |
| 95 | Increased cerebral lipofuscin (HP:0011813) | 2.57874558 |
| 96 | Pulmonary embolism (HP:0002204) | 2.56335082 |
| 97 | * Lethargy (HP:0001254) | 2.52032348 |
| 98 | Gout (HP:0001997) | 2.51183049 |
| 99 | Purpura (HP:0000979) | 2.49526021 |
| 100 | Hypoglycemic seizures (HP:0002173) | 2.48260956 |
| 101 | Spastic diplegia (HP:0001264) | 2.46554810 |
| 102 | Cerebral edema (HP:0002181) | 2.45365114 |
| 103 | Abnormal gallbladder morphology (HP:0012437) | 2.43422761 |
| 104 | Glomerulonephritis (HP:0000099) | 2.41812914 |
| 105 | Abnormality of T cells (HP:0002843) | 2.41046003 |
| 106 | Abnormal platelet volume (HP:0011876) | 2.38654744 |
| 107 | Malnutrition (HP:0004395) | 2.38442518 |
| 108 | Irritability (HP:0000737) | 2.37098991 |
| 109 | Cholelithiasis (HP:0001081) | 2.36672844 |
| 110 | Mitral stenosis (HP:0001718) | 2.34951390 |
| 111 | Cellulitis (HP:0100658) | 2.34843406 |
| 112 | Neonatal onset (HP:0003623) | 2.33929990 |
| 113 | Abnormal gallbladder physiology (HP:0012438) | 2.32957950 |
| 114 | Cholecystitis (HP:0001082) | 2.32957950 |
| 115 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.32316256 |
| 116 | Autoimmune thrombocytopenia (HP:0001973) | 2.31465882 |
| 117 | Cardiovascular calcification (HP:0011915) | 2.29895984 |
| 118 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.27965106 |
| 119 | Inflammation of the large intestine (HP:0002037) | 2.24517047 |
| 120 | Petechiae (HP:0000967) | 2.23602319 |
| 121 | Amyloidosis (HP:0011034) | 2.22919982 |
| 122 | Pustule (HP:0200039) | 2.22262775 |
| 123 | Gangrene (HP:0100758) | 2.21718347 |
| 124 | Esophageal varix (HP:0002040) | 2.20546634 |
| 125 | Sensorimotor neuropathy (HP:0007141) | 2.18831365 |
| 126 | Autoimmune hemolytic anemia (HP:0001890) | 2.17028803 |
| 127 | Pancreatitis (HP:0001733) | 2.16730643 |
| 128 | Vacuolated lymphocytes (HP:0001922) | 2.16318906 |
| 129 | Periodontitis (HP:0000704) | 2.15538119 |
| 130 | Anorexia (HP:0002039) | 2.13235436 |
| 131 | Hematochezia (HP:0002573) | 2.12471836 |
| 132 | Gingival bleeding (HP:0000225) | 2.11925501 |
| 133 | Enlarged kidneys (HP:0000105) | 2.11664481 |
| 134 | Late onset (HP:0003584) | 2.11243923 |
| 135 | Brushfield spots (HP:0001088) | 2.11007162 |
| 136 | Eosinophilia (HP:0001880) | 2.10715700 |
| 137 | Generalized aminoaciduria (HP:0002909) | 2.09732711 |
| 138 | Vomiting (HP:0002013) | 2.09691825 |
| 139 | Mucopolysacchariduria (HP:0008155) | 2.09043623 |
| 140 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.09043623 |
| 141 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.08959081 |
| 142 | Granulocytopenia (HP:0001913) | 2.08723147 |
| 143 | Abnormality of the peritoneum (HP:0002585) | 2.08025936 |
| 144 | Colitis (HP:0002583) | 2.07850096 |
| 145 | Osteomyelitis (HP:0002754) | 2.07648929 |
| 146 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07507622 |
| 147 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07507622 |
| 148 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07507622 |
| 149 | Menorrhagia (HP:0000132) | 2.07335328 |
| 150 | Increased mean platelet volume (HP:0011877) | 2.07292713 |
| 151 | Poikilocytosis (HP:0004447) | 2.07284264 |
| 152 | Episodic fever (HP:0001954) | 2.06475298 |
| 153 | Conjunctival telangiectasia (HP:0000524) | 2.05628900 |
| 154 | Abnormality of proline metabolism (HP:0010907) | 2.05618380 |
| 155 | Hydroxyprolinuria (HP:0003080) | 2.05618380 |
| 156 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.03937424 |
| 157 | Gastrointestinal inflammation (HP:0004386) | 2.03438679 |
| 158 | Glomerulopathy (HP:0100820) | 2.01799276 |
| 159 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01582554 |
| 160 | Recurrent bronchitis (HP:0002837) | 2.00973090 |
| 161 | Disinhibition (HP:0000734) | 2.00491555 |
| 162 | Thrombophlebitis (HP:0004418) | 1.98843359 |
| 163 | Abnormality of the gallbladder (HP:0005264) | 1.98154943 |
| 164 | Opisthotonus (HP:0002179) | 1.97830519 |
| 165 | Abnormality of the pleura (HP:0002103) | 1.97161564 |
| 166 | Spondylolisthesis (HP:0003302) | 1.96669480 |
| 167 | Interstitial pulmonary disease (HP:0006530) | 1.96582969 |
| 168 | Rickets (HP:0002748) | 1.96503489 |
| 169 | Hemorrhage of the eye (HP:0011885) | 1.96296279 |
| 170 | Alkalosis (HP:0001948) | 1.93483026 |
| 171 | Vertigo (HP:0002321) | 1.92888974 |
| 172 | Loss of speech (HP:0002371) | 1.92434842 |
| 173 | Increased IgE level (HP:0003212) | 1.91698719 |
| 174 | Abnormal cartilage morphology (HP:0002763) | 1.90044999 |
| 175 | Renal cortical cysts (HP:0000803) | 1.87044027 |
| 176 | Slow saccadic eye movements (HP:0000514) | 1.86207074 |
| 177 | Polyneuropathy (HP:0001271) | 1.85797207 |
| 178 | Abnormality of the endocardium (HP:0004306) | 1.85431408 |
| 179 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84946181 |
| 180 | Joint swelling (HP:0001386) | 1.84515808 |
| 181 | Abnormality of iron homeostasis (HP:0011031) | 1.84450816 |
| 182 | Fatigue (HP:0012378) | 1.84067188 |
| 183 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83801286 |
| 184 | Hypophosphatemic rickets (HP:0004912) | 1.82321458 |
| 185 | Abnormality of vitamin metabolism (HP:0100508) | 1.82211826 |
| 186 | Subacute progressive viral hepatitis (HP:0006572) | 1.81990898 |
| 187 | Elevated hepatic transaminases (HP:0002910) | 1.81262523 |
| 188 | Hyperglycemia (HP:0003074) | 1.77867878 |
| 189 | Proximal tubulopathy (HP:0000114) | 1.77460640 |
| 190 | Status epilepticus (HP:0002133) | 1.76587389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.89185874 |
| 2 | SIK1 | 4.51053775 |
| 3 | FGFR4 | 4.44684914 |
| 4 | ERN1 | 4.22388858 |
| 5 | RIPK4 | 3.75088633 |
| 6 | BLK | 3.74153055 |
| 7 | INSRR | 3.25152210 |
| 8 | TAOK3 | 3.06339715 |
| 9 | ERBB4 | 2.95042979 |
| 10 | MST1R | 2.40324062 |
| 11 | FES | 2.38264510 |
| 12 | MAP2K4 | 2.32993241 |
| 13 | MAP4K1 | 2.29621157 |
| 14 | JAK3 | 2.18406576 |
| 15 | PKN2 | 2.13624601 |
| 16 | ZAP70 | 2.10893374 |
| 17 | IRAK4 | 2.07458180 |
| 18 | TXK | 1.99833468 |
| 19 | FRK | 1.95759558 |
| 20 | SYK | 1.94911290 |
| 21 | CAMKK2 | 1.92122115 |
| 22 | MAPK11 | 1.89362589 |
| 23 | PRPF4B | 1.86403386 |
| 24 | PIK3CG | 1.81583057 |
| 25 | BTK | 1.81080261 |
| 26 | LATS1 | 1.80976474 |
| 27 | TEC | 1.80953050 |
| 28 | FLT3 | 1.77859482 |
| 29 | FGR | 1.70137918 |
| 30 | BMPR2 | 1.64574853 |
| 31 | TRIB3 | 1.64131955 |
| 32 | HCK | 1.63920505 |
| 33 | KIT | 1.63060699 |
| 34 | TYK2 | 1.57476901 |
| 35 | PTK6 | 1.53090289 |
| 36 | FGFR2 | 1.48608482 |
| 37 | DAPK2 | 1.46162797 |
| 38 | ABL2 | 1.40713181 |
| 39 | NEK9 | 1.37588978 |
| 40 | YES1 | 1.34072814 |
| 41 | LYN | 1.31484764 |
| 42 | MAP3K7 | 1.28099356 |
| 43 | ITK | 1.27262821 |
| 44 | PRKAA2 | 1.25574847 |
| 45 | LCK | 1.22808153 |
| 46 | JAK2 | 1.19590845 |
| 47 | GRK6 | 1.19399547 |
| 48 | KDR | 1.10984596 |
| 49 | PINK1 | 1.09510641 |
| 50 | ERBB2 | 1.09495986 |
| 51 | ACVR1B | 1.04224629 |
| 52 | IKBKB | 1.04219489 |
| 53 | MAP3K10 | 1.03839333 |
| 54 | JAK1 | 1.02697306 |
| 55 | GRK7 | 0.97653884 |
| 56 | MAPK4 | 0.96152961 |
| 57 | TBK1 | 0.95938609 |
| 58 | STK38L | 0.93369415 |
| 59 | MET | 0.92869077 |
| 60 | MAP3K14 | 0.92788527 |
| 61 | PRKCZ | 0.92225285 |
| 62 | CAMK1D | 0.89232314 |
| 63 | EPHB1 | 0.88772127 |
| 64 | PTK2B | 0.88625157 |
| 65 | MAP2K3 | 0.88618949 |
| 66 | EPHA3 | 0.87700073 |
| 67 | MATK | 0.84963770 |
| 68 | MAPK15 | 0.84578063 |
| 69 | MAP3K3 | 0.82367559 |
| 70 | TNK2 | 0.81429543 |
| 71 | MARK3 | 0.81378739 |
| 72 | RIPK1 | 0.80158900 |
| 73 | TRPM7 | 0.80126678 |
| 74 | IRAK2 | 0.78405374 |
| 75 | PRKACG | 0.77321276 |
| 76 | CDK6 | 0.75918875 |
| 77 | PRKAA1 | 0.73840705 |
| 78 | STK10 | 0.73566199 |
| 79 | CAMK2G | 0.73167277 |
| 80 | MAPK12 | 0.72455060 |
| 81 | CAMKK1 | 0.72390448 |
| 82 | SGK3 | 0.72246482 |
| 83 | GSK3A | 0.70034044 |
| 84 | TIE1 | 0.68228688 |
| 85 | CSK | 0.67465030 |
| 86 | PDGFRB | 0.66214422 |
| 87 | DYRK1B | 0.65878969 |
| 88 | MAP2K6 | 0.65683030 |
| 89 | NLK | 0.64355225 |
| 90 | TTN | 0.64157540 |
| 91 | CLK1 | 0.62897491 |
| 92 | IRAK3 | 0.62756450 |
| 93 | FGFR3 | 0.62748260 |
| 94 | FYN | 0.62054798 |
| 95 | MAP3K11 | 0.61921626 |
| 96 | MARK2 | 0.58818589 |
| 97 | PTK2 | 0.58559873 |
| 98 | MOS | 0.57651390 |
| 99 | KSR2 | 0.56987826 |
| 100 | GRK1 | 0.56464076 |
| 101 | SGK2 | 0.54898044 |
| 102 | MAPK7 | 0.54509632 |
| 103 | PDPK1 | 0.54347455 |
| 104 | PIM1 | 0.54077081 |
| 105 | HIPK2 | 0.53213146 |
| 106 | CDC42BPA | 0.53152018 |
| 107 | PRKCQ | 0.51927289 |
| 108 | ABL1 | 0.50546283 |
| 109 | EPHA4 | 0.50356410 |
| 110 | LRRK2 | 0.49742155 |
| 111 | TGFBR2 | 0.49131750 |
| 112 | CSF1R | 0.48312043 |
| 113 | RET | 0.47760490 |
| 114 | IGF1R | 0.46931142 |
| 115 | MAP2K1 | 0.46922888 |
| 116 | CSNK1G1 | 0.46786400 |
| 117 | IKBKE | 0.46700313 |
| 118 | STK38 | 0.44826997 |
| 119 | TAOK1 | 0.44325850 |
| 120 | ADRBK1 | 0.43044039 |
| 121 | SGK223 | 0.42150550 |
| 122 | SGK494 | 0.42150550 |
| 123 | PDK3 | 0.40737558 |
| 124 | PDK4 | 0.40737558 |
| 125 | WNK1 | 0.40611549 |
| 126 | SIK3 | 0.40055116 |
| 127 | GRK5 | 0.39763624 |
| 128 | MELK | 0.39136794 |
| 129 | PKN1 | 0.39090813 |
| 130 | PIK3CA | 0.38835597 |
| 131 | MAP3K5 | 0.38823162 |
| 132 | AKT3 | 0.38646416 |
| 133 | PRKD2 | 0.37828764 |
| 134 | CAMK1G | 0.37605997 |
| 135 | PRKCG | 0.36288989 |
| 136 | PRKD1 | 0.35988735 |
| 137 | MAPKAPK2 | 0.35799430 |
| 138 | MAP3K13 | 0.35790773 |
| 139 | STK11 | 0.35354115 |
| 140 | TAOK2 | 0.34810078 |
| 141 | ICK | 0.34691999 |
| 142 | MTOR | 0.34384121 |
| 143 | MAP3K2 | 0.33670316 |
| 144 | PDK1 | 0.33156533 |
| 145 | MAP3K6 | 0.33063672 |
| 146 | CDK4 | 0.32521572 |
| 147 | EGFR | 0.31967239 |
| 148 | CAMK4 | 0.29166589 |
| 149 | MAP3K1 | 0.29119437 |
| 150 | PBK | 0.28953037 |
| 151 | PRKCA | 0.28462690 |
| 152 | MAP2K2 | 0.28041613 |
| 153 | PAK3 | 0.27668708 |
| 154 | CSNK1G2 | 0.26460746 |
| 155 | LATS2 | 0.26047603 |
| 156 | IRAK1 | 0.25180789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.47274526 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.66740468 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.39030883 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35975087 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08646390 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.81537394 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72116985 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.67857728 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.65122190 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.59896796 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.56611346 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51545021 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50530710 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.41435970 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28632570 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 2.23289619 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.21322713 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14984885 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14554139 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 2.08038813 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 2.05193912 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.02315306 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.01569799 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.98003638 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93156589 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92980727 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.92935898 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91527433 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90274806 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.90240884 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.87403635 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.86194481 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.83842456 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.83601106 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81508888 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.73884877 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.73579681 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73214160 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70053965 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.69477595 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68167680 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.61486119 |
| 43 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.58045831 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.58024806 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.57406776 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56516913 |
| 47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56113922 |
| 48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.55909447 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 1.55525314 |
| 50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55450249 |
| 51 | * beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.55391527 |
| 52 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.55204266 |
| 53 | Bile secretion_Homo sapiens_hsa04976 | 1.55045618 |
| 54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.54599505 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 1.51984769 |
| 56 | Measles_Homo sapiens_hsa05162 | 1.47058316 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 1.45455534 |
| 58 | Legionellosis_Homo sapiens_hsa05134 | 1.45308966 |
| 59 | Other glycan degradation_Homo sapiens_hsa00511 | 1.44900262 |
| 60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.43505103 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43334909 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42539930 |
| 63 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40895683 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40542021 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.39497986 |
| 66 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.39353840 |
| 67 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37481763 |
| 68 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.37344977 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.36313291 |
| 70 | * Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.35323620 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 1.34032837 |
| 72 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33611174 |
| 73 | Influenza A_Homo sapiens_hsa05164 | 1.32678157 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 1.32378050 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.32031155 |
| 76 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30727317 |
| 77 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30586434 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30268957 |
| 79 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29575177 |
| 80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28756014 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28728039 |
| 82 | ABC transporters_Homo sapiens_hsa02010 | 1.23136506 |
| 83 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21166381 |
| 84 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19502972 |
| 85 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16587092 |
| 86 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15974967 |
| 87 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14286950 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06368049 |
| 89 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03992800 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03719047 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01608723 |
| 92 | Hepatitis B_Homo sapiens_hsa05161 | 1.01088105 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00225572 |
| 94 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00224635 |
| 95 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99864517 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99644017 |
| 97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97554511 |
| 98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95455954 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95437155 |
| 100 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93536880 |
| 101 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93427331 |
| 102 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91360374 |
| 103 | Shigellosis_Homo sapiens_hsa05131 | 0.90036031 |
| 104 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88862173 |
| 105 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88740698 |
| 106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88326178 |
| 107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86488563 |
| 108 | Salmonella infection_Homo sapiens_hsa05132 | 0.83576700 |
| 109 | Lysine degradation_Homo sapiens_hsa00310 | 0.83327554 |
| 110 | Apoptosis_Homo sapiens_hsa04210 | 0.79302185 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77377174 |
| 112 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77187350 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76324403 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72832723 |
| 115 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71938109 |
| 116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67429100 |
| 117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67394437 |
| 118 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67252777 |
| 119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66195938 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65186487 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64013570 |
| 122 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63945871 |
| 123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63076494 |
| 124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62609653 |
| 125 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60605056 |
| 126 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59769422 |
| 127 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59216226 |
| 128 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57833308 |
| 129 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57703863 |
| 130 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56585326 |
| 131 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56131731 |
| 132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55413692 |
| 133 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53062152 |
| 134 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51815564 |
| 135 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50356761 |
| 136 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49222081 |
| 137 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48798867 |
| 138 | Endocytosis_Homo sapiens_hsa04144 | 0.48600021 |
| 139 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46968916 |
| 140 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46182682 |
| 141 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45584758 |
| 142 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45346973 |
| 143 | Renin secretion_Homo sapiens_hsa04924 | 0.44399339 |
| 144 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.44372704 |
| 145 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43254252 |
| 146 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41592325 |
| 147 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39286492 |
| 148 | Focal adhesion_Homo sapiens_hsa04510 | 0.38204073 |
| 149 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35697705 |
| 150 | Prion diseases_Homo sapiens_hsa05020 | 0.34641873 |
| 151 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33176246 |
| 152 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32948281 |
| 153 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32144398 |
| 154 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31875417 |
| 155 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27835714 |
| 156 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25027441 |
| 157 | Insulin resistance_Homo sapiens_hsa04931 | 0.24746589 |
| 158 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23567669 |
| 159 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20777670 |
| 160 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17448720 |
| 161 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16852784 |
| 162 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11293476 |
| 163 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03839974 |
| 164 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2302005 |
| 165 | Amoebiasis_Homo sapiens_hsa05146 | -0.2297883 |
| 166 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2133285 |
| 167 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2095985 |
| 168 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2084305 |
| 169 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1778117 |
| 170 | Mineral absorption_Homo sapiens_hsa04978 | -0.1723117 |
| 171 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1710598 |
| 172 | Hepatitis C_Homo sapiens_hsa05160 | -0.1667234 |
| 173 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1573588 |
| 174 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1537436 |
| 175 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1535938 |
| 176 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1490851 |
| 177 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1457621 |
| 178 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1179609 |
| 179 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1007785 |
| 180 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0845148 |
| 181 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0711355 |
| 182 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0560055 |
| 183 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0387706 |
| 184 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0378005 |

